Quote:
Originally Posted by SkinnyPupp
Financial rewards, yes, that's the most important thing.
|
For better or for worse, the world runs on an incentive system. If there is no profit to be made, what incentive is there for Big Pharma to work on those new drugs, whatever those new drugs may be?
If you count on the world running purely on altruism, it is going to be a very, very bad place...
The failure rate for new medicine development is extremely high, and I continue to be amazed that we have as many COVID vaccines as we do now in record time, despite whatever flaws they may have.
Personally, I'd say it is a bad situation either way -- I just don't know which option would be worse. Respect the patents and production couldn't come fast enough. Allow the generics, and Big Pharma would lose incentive to do this again the next when we need their expertise. How do you choose between a rock and a hard place?